CD164 promotes lung tumor-initiating cells with stem cell activity and determines tumor growth and drug resistance via Akt/mTOR signaling
Wei‐Liang Chen(National Taiwan University), James Yi‐Hsin Chan(National Defense Medical Center)
Cited by 25
Related Papers
MiR-21 Indicates Poor Prognosis in Tongue Squamous Cell Carcinomas as an Apoptosis Inhibitor
|Clinical Cancer Research|2009|435
CD164 regulates proliferation, progression, and invasion of human glioblastoma cells
|Oncotarget|2019|19
Supplementary Data from MiR-21 Indicates Poor Prognosis in Tongue Squamous Cell Carcinomas as an Apoptosis Inhibitor
|Unknown|2023|0